Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Diagnostic Trial for Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers

NCT04891029 is registered in ClinicalTrials.gov with McGill University as lead sponsor.

NCT NCT04891029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04891029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Diagnostic Trial for Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
Lead sponsor
McGill University
Phase
Not applicable
Overall status
Recruiting
Start date
May 10, 2021
Completion date
November 30, 2028
Enrollment
5,600 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diagnoses disease